OnKure reprices underwater options to $4.14; ~1.7M shares affected

OnKure Therapeutics, Inc.

Board approved repricing of eligible options with exercise price >= $10.00 to $4.14, effective Aug 7, 2026.
CEO Saccomano: 571,423 options repriced; CMO Agresta: 149,984; CFO Leverone: 141,714.
Repriced options total ~1.7M shares; original exercise prices ranged $13.99-$24.59.
Retention requirement: 18 months for senior management, 1 year for others; no change to term, vesting, or share count.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.